A new study found that a blood-based biomarker called phosphorylated tau 217 (p-tau217) can predict a woman's risk of developing dementia up to 25 years before symptoms appear. Higher levels of p-tau217 were strongly associated with future mild cognitive impairment and Alzheimer's disease among cognitively healthy older women
Representational image
A study has found that a women's risk of developing dementia may be predicted 25 years before symptoms begin through a test of a blood-based biomarker called 'phosphorylated tau 217' -- a protein linked to the brain changes seen in Alzheimer's disease.
Higher levels of phosphorylated tau 217, or p-tau217, were strongly associated with future mild cognitive impairment and dementia -- of which Alzheimer's disease is the most common form -- among older women who were cognitively healthy at the study's start.
"Our study suggests we may be able to identify women at elevated risk for dementia decades before symptoms emerge," first author Aladdin H. Shadyab, associate professor of public health and medicine at the University of California San Diego, said.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
